基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 生化试剂 激动剂抑制剂 H3B-6527 H3B-6527
  • aladdin 阿拉丁 H414109 H3B-6527 1702259-66-2 97%

aladdin 阿拉丁 H414109 H3B-6527 1702259-66-2 97%

H3B-6527
1702259-66-2
499.90 5mg 起订
799.90 10mg 起订
1599.90 25mg 起订
上海 更新日期:2025-05-16

上海阿拉丁生化科技股份有限公司

VIP3年
联系人:阿拉丁客服
电话:6206333拨打
手机:13167063860 拨打
邮箱:anhua.mao@aladdin-e.com

产品详情:

中文名称:
H3B-6527
英文名称:
H3B-6527
CAS号:
1702259-66-2
品牌:
阿拉丁
产地:
上海
保存条件:
-20°C储存
纯度规格:
≥97%
产品类别:
小分子和化合物库
分子式:
C29H34Cl2N8O4
分子量:
629.54
运输条件:
超低温运输
产品规格:
25mg、5mg、10mg
货号:
H414109
是否进口:

中文名:H3B-6527

英文名:H3B-6527

纯度:≥97%

货号:H414109

Cas号:1702259-66-2

存储温度:-20°C储存

运输条件:超低温运输

产品介绍:

Information

H3B-6527 H3B-6527 is a highly selective covalent FGFR4 inhibitor with an IC50 value of <1.2 nM and at least 250-fold selectivity over FGFR1-3 (IC50 values of 320, 1,290 and 1,060 nM respectively).


Targets

FGFR4 (Cell-free assay) <1.2 nM


In vitro

H3B-6527 shows robust inhibition of the target kinase FGFR4 with an IC50 value of <1.2 nmol/L and at least 250-fold selectivity over FGFR1-3 (IC50 values of 320, 1,290 and 1,060 nmol/L respectively). TAOK2, JNK2, and CSF1R are also less sensitive to H3B-6527 treatment with IC50 values of 690, >10,000, and >10,000 nmol/L, respectively. H3B-6527 inhibits FGFR4 signaling, proliferation, and leads to apoptosis in a HCC cell line (Hepatocellular carcinoma). Treatment on Hep3B cells leads to robust activation of caspase-3/7, an apoptotic marker, in a concentration-dependent manner, indicating FGFR4 inhibition by H3B-6527 leads to cell death in HCC cell lines. H3B-6527 has the selectivity and the selective dependence on FGFR4 across cancer types.


In vivo

In the Hep3B human HCC xenograft mouse model, H3B-6527 shows dose-proportional plasma exposures and greater than dose-proportional tumor exposures within the dose range evaluated (30, 100, and 300 mg/kg). The H3B-6527 pharmacodynamic response as measured by CYP7A1 mRNA and pERK1/2 protein levels is dose dependent, with higher doses leading to sustained responses. Oral treatment of H3B-6527, twice daily, inhibits xenograft growth in a dose-dependent manner in nude mice, with the 300 or 100 mg/kg twice daily, significantly inhibiting tumor growth in both Hep3B subcutaneous and orthotopic xenograft model and causing tumor regressions in the subcutaneous xenograft model. Palbociclib can enhance H3B-6527 efficacy and promote tumor regression in JHH-7 model where H3B-6527 as a single agent can only lead to tumor stasis.


Cell Research(from reference)

Cell lines:Hep3B cells 

Concentrations:100 and 300 nmol/L 

Incubation Time:0.5, 1, 2, 4, 8, and 24 hours 


查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/H414109.html


BDBM249396 ; N-(2-((6-(((2,6-Dichloro-3,5 dimethoxyphenyl) carbamoyl) (methyl)amino)pyrimidin-4-yl)amino)-5-(4-ethylpiperazin-1-yl)phenyl)prop-2-enamide ; 4HTE364XIK ; H3B 6527;H3B6527;Eisai;H3 Biomedicine

公司简介

上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。 阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内外电商平台。

成立日期 (18年)
注册资本 14130.676万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 生物化工,化学试剂

H3B-6527相关厂家报价

内容声明
拨打电话 立即询价